Yu W - Search Results

1

Response to Prieto et al, "RE: External validation of the Melanoma Institute Australia sentinel lymph metastasis risk prediction tool using the National Cancer Database".

Freeman SC, Paz Munoz E, Latour E, Lim JY, Yu W. Freeman SC, et al. Among authors: yu w. J Am Acad Dermatol. 2024 Sep;91(3):e75-e76. doi: 10.1016/j.jaad.2024.04.074. Epub 2024 May 11. J Am Acad Dermatol. 2024. PMID: 38740332 No abstract available.

2

Minority enrollment in melanoma clinical trials.

Munoz EP, Patel SP, Leachman SA, Yu NY, Yu WY. Munoz EP, et al. J Am Acad Dermatol. 2023 Nov;89(5):1052-1054. doi: 10.1016/j.jaad.2023.06.043. Epub 2023 Jul 5. J Am Acad Dermatol. 2023. PMID: 37419186 No abstract available.

3

External validation of the Melanoma Institute Australia Sentinel Node Metastasis Risk Prediction Tool using the National Cancer Database.

Freeman SC, Paz Munoz E, Latour E, Lim JY, Yu W. Freeman SC, et al. Among authors: yu w. J Am Acad Dermatol. 2023 Nov;89(5):967-973. doi: 10.1016/j.jaad.2023.07.011. Epub 2023 Jul 15. J Am Acad Dermatol. 2023. PMID: 37454700

4

Tranexamic Acid Prevention of Hemorrhagic Complications Following Interpolated Flap Repair: A Single-Center, Retrospective, Cohort Study.

Freeman SC, Heath MS, Neill B, Morris C, Lucero OM, Yu W, Bar A, Leitenberger JJ. Freeman SC, et al. Among authors: yu w. Dermatol Surg. 2023 Dec 1;49(12):1139-1142. doi: 10.1097/DSS.0000000000003931. Epub 2023 Sep 14. Dermatol Surg. 2023. PMID: 37712760

5

Expression of programmed cell death ligand 1 and programmed cell death 1 in cutaneous warts.

Yu WY, Berger TG, North JP, Laszik Z, Cohen JN. Yu WY, et al. J Am Acad Dermatol. 2019 Nov;81(5):1127-1133. doi: 10.1016/j.jaad.2019.02.063. Epub 2019 Mar 11. J Am Acad Dermatol. 2019. PMID: 30872155

6

To Improve Melanoma Outcomes, Focus on Risk Stratification, Not Overdiagnosis.

Kulkarni RP, Yu WY, Leachman SA. Kulkarni RP, et al. JAMA Dermatol. 2022 May 1;158(5):485-487. doi: 10.1001/jamadermatol.2022.0097. JAMA Dermatol. 2022. PMID: 35385059 No abstract available.

7

Statin use does not impact sentinel lymph node metastasis and recurrence in melanoma patients: an 844-patient retrospective study.

Jing FZ, Pazhava A, Todd A, Meves A, Yu WY. Jing FZ, et al. Int J Dermatol. 2024 Jun 12. doi: 10.1111/ijd.17320. Online ahead of print. Int J Dermatol. 2024. PMID: 38867411 No abstract available.

8

Generalized benign cutaneous reaction to cytarabine.

Ruben BS, Yu WY, Liu F, Truong SV, Wang KC, Fox LP. Ruben BS, et al. J Am Acad Dermatol. 2015 Nov;73(5):821-8. doi: 10.1016/j.jaad.2015.07.010. Epub 2015 Aug 29. J Am Acad Dermatol. 2015. PMID: 26321388

9

Computational Drug Repositioning Identifies Statins as Modifiers of Prognostic Genetic Expression Signatures and Metastatic Behavior in Melanoma.

Yu WY, Hill ST, Chan ER, Pink JJ, Cooper K, Leachman S, Lund AW, Kulkarni R, Bordeaux JS. Yu WY, et al. J Invest Dermatol. 2021 Jul;141(7):1802-1809. doi: 10.1016/j.jid.2020.12.015. Epub 2021 Jan 6. J Invest Dermatol. 2021. PMID: 33417917 Free PMC article.

10

Statin use is associated with improved overall survival in patients with melanoma.

Madison CJ, Heinrich MC, Thompson RF, Yu WY. Madison CJ, et al. Melanoma Res. 2022 Aug 1;32(4):291-294. doi: 10.1097/CMR.0000000000000822. Epub 2022 May 13. Melanoma Res. 2022. PMID: 35579692 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16,614 results

Search Page

Filters